Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features
Conclusions: Our results suggest that serum exosomal GGT activity could be a clinically useful marker for advanced clinicopathological features of RCC patients, and its combined use with conventional diagnostic modalities may improve the diagnosis and treatment of patients.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Kidney Cancer | Prostate Cancer | Renal Cell Carcinoma | Study